News

Below you'll find the ALLG's latest news announcements.

 
Importance of Clinical Trials Feb 2018
This year, almost 16,000 Australians will begin a long and gruelling journey with blood cancer. Decades of research have led to vastly improved outcomes for blood cancer patients with survival rates rising 29 per cent. Although improved treatments and care are helping more people survive, sadly an Australian loses their life to blood cancer every two hours. more ...
 
Senate Report into Funding for Research into Cancers with Low Survival Rates Jan 2018
The Australasian Leukaemia & Lymphoma Group (ALLG) welcomed the November 2017 release of the Select Committee Report into funding for research into cancers with low survival rates. The report called on the Federal Government to make research into low–survival cancers a national health priority as funding was not as easily accessible for different treatment options as it is for other cancers. more ...
 
November Scientific Meeting Highlights Nov 2017
During November 2017, The ALLG held its biannual Scientific Meeting in Sydney. The guest speaker, Professor Nik Zeps from the Australian Clinical Trials Alliance (ACTA) presented the topic "The Australian Clinical trials Alliance — Developing a work plan for the future of investigator driven research in Australia". This was a great opportunity for members to understand the relevance and importance of ACTA. more ...
 
Economic Evaluation of Clinical Trials Oct 2017
The ALLG applauded the launch of the landmark report called "Economic evaluation of investigator-initiated clinical trials conducted by networks". Released in August 2017, by the Australian Commission on Safety and Quality in Health Care and the Australian Clinical Trials Alliance (ACTA), the welcomed report analysed 25 Australian clinical trials initiated by clinicians. more ...
 
Janey Stone — A Celebration Sep 2017
Every year, hardworking people dedicate their lives to saving others. One such person is Janey Stone, who dedicated her life to science. more ...
 
Consultations Aug 2017
ALLG members need a voice and a connection with Government bodies, the research and pharmaceutical sectors and each other. To facilitate this we have recently put considerable concentrated focus toward opportunities to create greater awareness of the ALLG and the members research efforts. more ...
 
Scientific Advisory Committee (SAC) Chair Elect July 2017
The ALLG Scientific Advisory Committee (SAC) has appointed A/Prof Peter Mollee as the Chair Elect. Peter's post as SAC Chair will commence after the November General Meeting. more ...
 
The Strategic Narrative: A Better Way To Communicate Jun 2017
The ALLG is pleased to announce the launch of our Corporate Narrative and new Brand Identity. more ...
 
May Scientific Meeting Highlights May 2017
The ALLG held its most recent biannual Scientific Meeting in May 2017. ALLG Scientific Meetings are internal working events, which review regularly the group's trial portfolio. Among the many highlights were the three international speakers. more ...
 
Submission to the 2017 Senate Inquiry: Funding for Research into Cancers with
Low Survival Rates
Apr 2017
The ALLG welcomes the government initiative to establish a select committee to be known as the Select Committee into Funding for Research into Cancers with Low Survival Rates to inquire and report on the impact of health research funding models on the availability of funding for research into cancers with low survival rates.

The ALLG, along with 120 other organisations and individuals, submitted to the Senate Inquiry. The committee will review and consider the submissions, with a view to issue a report by 28 November 2017. Information on the inquiry and submissions received by the committee are available on the inquiry website here.

ALLG's submission can be accessed here.
 
Research and Clinical Care Priorities Mar 2017
On the 16 November 2016 the ALLG participated in a summit with 14 fellow blood cancer research and not for profit organisations to explore areas of potential future collaboration. more ...
 
National Blood Cancer Registry (NBCR) Feb 2017
The NBCR began in 2012 as an AML registry under the leadership of Associate Professor Andrew Wei. It has since grown to encompass additional types of blood cancers and has been renamed the National Blood Cancer Registry (NBCR). more ...
 
Life Members Jan 2017
The ALLG currently has three life members. At the October 2016 Scientific Meeting, three more people were awarded life membership in recognition of their major contribution to the ALLG. more ...